Systemic lupus erythematosus and critical illness polyneuropathy
More details
Hide details
Rehabilitation Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
Department of Rehabilitation, First Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
Submission date: 2020-07-28
Final revision date: 2021-05-06
Acceptance date: 2021-08-13
Online publication date: 2021-08-26
Publication date: 2021-09-02
Reumatologia 2021;59(4):265-269
Systemic lupus erythematosus (SLE) is a chronic disease of connective tissue with multi-organ invol­vement. Manifestation in the nervous system is one of the most difficult symptoms to assess and interpret. The aim of the study is to indicate diagnostic problems in patients with SLE in whom neurological symptoms are present at the time of diagnosis of SLE but also with complications that occurred after diagnosis.
In the presented case, the appearance of flaccid tetraparesis with areflexia suggested peripheral damage to the nervous system. In the electromyography performed in this patient, acute axonal polyneuropathy was mainly suspected. Further differential diagnosis should consider other acute and subacute developing polyneuropathies. Guillain-Barré polyneuropathy deserves special attention.
To our knowledge, this is the first case documented in the literature of the coexistence of critical illness polyneuropathy and SLE.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599–608, DOI: 10.1002/1529-0131(199904) 42:4<599::AID-ANR2>3.0.CO;2-F.
Shaban A, Leira EC. Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep 2019; 19: 97, DOI: 10.1007/s11910-019-1012-1.
Gao Z, Li X, Peng T, et al. Systemic lupus erythematosus with Guillian-Barre syndrome: A case report and literature review. Medicine (Baltimore) 2018; 97: e11160, DOI: 10.1097/MD.0000000000011160.
López-López CO, Montes Castillo ML, Soto-Fajardo RC, et al. Peripheral neuropathies in rheumatic diseases: More diverse and frequent than expected. A cross-sectional study. Int J Rheum Dis 2020; 23: 226–232, DOI: 10.1111/1756-185X.13755.
Victor M, Ropper AH. Neurologia Adamsa i Viktora. 8th ed. Czelej, Lublin 2003: 322–335.
Coomes EA, Haghbayan H, Spring J, Mehta S. Fulminant Guillain-Barré syndrome in a patient with systemic lupus erythematosus. BMJ Case Rep 2019; 12: bcr-2018-226634, DOI: 10.1136/bcr-2018-226634.
Bolton CF. Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med 2000; 26: 1179–1180, DOI: 10.1007/s001340000622.
Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1553–1666, DOI: 10.1016/S0140-6736(05)67665-9.
Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 2017; 13: 799–814, DOI: 10.1080/1744666X.2017.1327352.
Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol Scand 2002; 105: 44–50, DOI: 10.1034/ j.1600-0404.2002.00099.x.
Kokubun N, Nishibayashi M, Uncini A, et al. Conduction block in acute motor axonal neuropathy. Brain 2010; 133: 2897–2908, DOI: 10.1093/brain/awq260.
Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci 1999; 168: 121–126, DOI: 10.1016/s0022-510x(99)00180-x.
Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 2004; 101: 11404–11409, DOI: 10.1073/pnas.0402391101.
Tam CC, Rodrigues LC, O’Brien SJ. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000–2001. Clin Infect Di 2003; 37: 307–310, DOI: 10.1086/ 375845.
Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10: 931–941, DOI: 10.1016/S1474-4422(11)70178-8.
Shepherd S, Batra A, Lerner DP. Review of critical illness myo­pathy and neuropathy. Neurohospitalist 2017; 7: 41–48, DOI: 10.1177/1941874416663279.
Zhou C, Wu L, Ni F, et al. Critical illness polyneuropathy and myopathy: a systematic review. Neural Regen Res 2014; 9: 101–110, DOI: 10.4103/1673-5374.125337.
Oud L. Epidemiology and outcomes of sepsis among hospitali­zations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study. J Intensive Care 2020; 8: 3, DOI: 10.1186/s40560-019-0424-y.
Arce-Salinas CA, Villasenor-Ovies P. Infections and systemic lupus erythematosus. In: Systemic lupus erythematosus. Almoalim H (ed.). IntechOpen 2012: 407–428, DOI: 10.5772/ 27509.
Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve 2013; 47: 452–463, DOI: 10.1002/mus.23615.
Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008; 79: 838–841, DOI: 10.1136/jnnp.2007.142430.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top